{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"","title":"IPOs, Chips, and Clinical AI: The Infrastructure Shift","description":"Claire and Peter break down a packed day in AI as the story moves from flashy demos to capital, governance, and real-world deployment. They unpack SpaceX’s IPO filing and how AI investment, Musk-linked related-party ties, and control structures could reshape risk for partners—and what OpenAI’s reported IPO preparations might mean for enterprise contracts and pricing. Then they look at Washington’s proposed voluntary pre-release reviews for frontier models, Nvidia’s blowout quarter alongside its effective exit from China’s AI chip market, and Singtel’s push into sovereign GPU-as-a-Service. The episode also covers Intuit’s major restructuring, a milestone EU certification for an AI-native EHR platform, retail wins from cleaner product data pipelines, and a new Nature paper on AI systems that can build scientific software—faster than humans, with big implications for verification and safety.","author_name":"Six & Flow"}